Journal of Affective Disorders
Volume 82, Issue 3 , Pages 453-459, 1 November 2004

Neuropsychological functioning in major depression and responsiveness to selective serotonin reuptake inhibitors antidepressants

  • Orli Kampf-Sherf

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +972-52-710836; fax: +972-2-5813288.
    • Department of Psychology, Hebrew University, POB 24288, Jerusalem 91242, Israel
  • ,
  • Zoli Zlotogorski

      Affiliations

    • Hebrew University of Jerusalem, Jerusalem, Israel
  • ,
  • Asaf Gilboa

      Affiliations

    • Department of Psychology, Hebrew University, POB 24288, Jerusalem 91242, Israel
  • ,
  • Lynn Speedie

      Affiliations

    • Kennedy Krieger Institute, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA
  • ,
  • Jossef Lereya

      Affiliations

    • Shalvata Psychiatric Health Center, Hod Hasharon, Israel
  • ,
  • Paula Rosca

      Affiliations

    • Winnick Clinic, Talbieh Mental Health Center, Jerusalem, Israel
  • ,
  • Yehuda Shavit

      Affiliations

    • Department of Psychology, Hebrew University, POB 24288, Jerusalem 91242, Israel

Received 22 April 2003; received in revised form 27 February 2004; accepted 27 February 2004.

Abstract 

Background: Only two thirds of patients with major depression (MD) respond to antidepressants. Thus, far applicable predictors of responsiveness to selective serotonergic reuptake inhibitors (SSRIs) have not been found. Cumulative evidence linking serotonergic depletion and cognition led us to hypothesize that the neuropsychological functioning of major depression patients may predict their responsiveness to SSRI antidepressants. Methods: Fifty-five patients meeting DSM-IV criteria for major depression and strict inclusion and exclusion criteria underwent an extensive clinical and neuropsychological assessment prior to the initiation of selective serotonergic treatment. Following 6 weeks of treatment, severity of depression was reassessed, yielding a responsiveness score by which classification of each subject as a responder or nonresponder was made. The study was double blind. Results: Logistic regression yielded neuropsychological indices, which significantly predicted the probability of depressed patients to respond favorably to SSRIs. Responders were characterized by better functioning in “simple” tasks and by worse functioning in “complex” tasks compared to nonresponders. No differences were found for more lateralized right or left hemisphere functions between responders and nonresponders. Limitations: Drug treatment comprised of SSRIs but was not standardized. Responsiveness was assessed following 6 weeks of treatment providing for initial amelioration rather than full remission. Placebo response was not controlled for. These limitations may influence the interpretation of the findings. Conclusions: The present findings suggest that responders and nonresponders to SSRIs might be distinguished by their neuropsychological functioning before treatment. If our findings are replicated, more efficient treatment might be practiced.

Keywords:  Serotonin, Major depression, Neuropsychological assessment, Prediction of treatment responsiveness

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0165-0327(04)00088-6

doi:10.1016/j.jad.2004.02.006

Journal of Affective Disorders
Volume 82, Issue 3 , Pages 453-459, 1 November 2004